Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.00%11.43B | -11.81%1.93B | 14.68%2.74B | -37.50%10.99B | -30.27%3B | -42.77%3.42B | -30.12%2.18B | -42.91%2.39B | 36.44%17.58B | 68.59%4.3B |
| Cost of revenue | 14.75%3.35B | -5.03%604M | 14.58%786M | -16.28%2.92B | -20.21%828.82M | -27.87%764.18M | 12.21%636M | -16.01%686M | 7.65%3.48B | 44.79%1.04B |
| Gross profit | 0.11%8.08B | -14.72%1.32B | 14.79%1.96B | -42.74%8.07B | -33.48%2.17B | -45.98%2.65B | -39.46%1.55B | -49.46%1.7B | 46.08%14.1B | 77.91%3.26B |
| Operating expense | 8.33%3.16B | 8.78%731M | 3.84%703M | -2.60%2.92B | -5.93%803.09M | -2.80%765.91M | -7.45%672M | 7.77%677M | 1.43%3B | 6.20%853.67M |
| Staff costs | 10.19%1.29B | ---- | ---- | 6.76%1.17B | ---- | ---- | ---- | ---- | 8.42%1.09B | ---- |
| Selling and administrative expenses | -1.91%410M | ---- | ---- | -27.36%418M | ---- | ---- | ---- | ---- | -20.98%575.45M | ---- |
| -General and administrative expense | -1.91%410M | ---- | ---- | -27.36%418M | ---- | ---- | ---- | ---- | 14.21%575.45M | ---- |
| Research and development costs | 17.04%783M | ---- | ---- | 10.49%669M | ---- | ---- | ---- | ---- | 2.22%605.47M | ---- |
| Depreciation and amortization | -6.25%45M | ---- | ---- | -9.49%48M | ---- | ---- | ---- | ---- | 17.58%53.03M | ---- |
| -Depreciation | -6.25%45M | ---- | ---- | -9.49%48M | ---- | ---- | ---- | ---- | 17.58%53.03M | ---- |
| Other operating expenses | 3.41%636M | ---- | ---- | -7.92%615M | ---- | ---- | ---- | ---- | 15.38%667.89M | ---- |
| Operating profit | -4.54%4.92B | -32.73%590M | 22.01%1.25B | -53.57%5.16B | -43.24%1.37B | -54.24%1.89B | -52.14%877M | -62.56%1.03B | 65.77%11.1B | 133.90%2.41B |
| Net non-operating interest income (expenses) | 82.93%75M | 60.00%16M | 100.00%20M | 332.90%41M | 30.17%9.98M | 52,361.90%11.02M | 71,328.57%10M | 465.93%10M | 1,707.44%9.47M | 63,808.33%7.67M |
| Non-operating interest income | 82.93%75M | 60.00%16M | 100.00%20M | 332.90%41M | 30.17%9.98M | 52,361.90%11.02M | 71,328.57%10M | 465.93%10M | 436.30%9.47M | 63,808.33%7.67M |
| Net investment income | 83.52%167M | -14.04%98M | 1,112.50%97M | 282.00%91M | 35.26%-77.9M | -34.44%46.9M | 7,575.41%114M | 2,431.65%8M | -6,437.26%-50M | -286,402.38%-120.33M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 16.67%7M | 50.00%3M | -33.33%2M | -16.79%6M | -126.13%-475K | -6.41%1.48M | 137.25%2M | 0.87%3M | 969.88%7.21M | 1,080.52%1.82M |
| Income before tax | -2.36%5.17B | -29.31%709M | 30.67%1.37B | -52.20%5.29B | -43.57%1.3B | -53.67%1.94B | -45.25%1B | -61.80%1.05B | 62.22%11.07B | 123.11%2.3B |
| Income tax | -8.23%1.39B | -34.15%189M | 32.24%402M | -53.04%1.52B | -40.85%349.91M | -54.37%577.09M | -47.37%287M | -63.43%304M | 61.02%3.23B | 101.10%591.56M |
| Net income | -0.03%3.77B | -27.41%519M | 30.03%970M | -51.85%3.77B | -44.51%946.38M | -53.34%1.37B | -44.43%715M | -61.09%746M | 62.73%7.84B | 131.91%1.71B |
| Net income continuous operations | 0.00%3.77B | -27.37%520M | 30.03%970M | -51.85%3.77B | -44.51%946.38M | -53.37%1.37B | -44.35%716M | -61.09%746M | 62.73%7.84B | 131.91%1.71B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -0.03%3.77B | -27.41%519M | 30.03%970M | -51.85%3.77B | -44.51%946.38M | -53.34%1.37B | -44.43%715M | -61.09%746M | 62.73%7.84B | 131.91%1.71B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -0.03%3.77B | -27.41%519M | 30.03%970M | -51.85%3.77B | -44.51%946.38M | -53.34%1.37B | -44.43%715M | -61.09%746M | 62.73%7.84B | 131.91%1.71B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.01%198.12 | -27.39%27.255 | 30.06%50.965 | -51.85%198.13 | -44.50%49.69 | -53.35%71.72 | -44.43%37.535 | -61.06%39.185 | 62.72%411.47 | 131.90%89.535 |
| Diluted earnings per share | -0.01%198.12 | -27.41%27.2459 | 30.06%50.965 | -51.85%198.13 | -44.51%49.6816 | -53.35%71.72 | -44.43%37.535 | -61.06%39.185 | 62.72%411.47 | 131.90%89.535 |
| Dividend per share | 66.67%100 | 100.00%40 | 0 | -52.00%60 | -57.89%40 | 0 | -33.33%20 | 0 | 61.29%125 | 80.95%95 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |